Login Register Cart 0
Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

An Overview of Nanoformulated Nutraceuticals and their Therapeutic Approaches

Author(s): Shaoli De, Agraharam Gopikrishna, Vedhantham Keerthana, Agnishwar Girigoswami and Koyeli Girigoswami*

Volume 17, Issue 4, 2021

Published on: 01 September, 2020

Page: [392 - 407] Pages: 16

DOI: 10.2174/1573401316999200901120458

Price: $65

Abstract

Background: Economic development and vast changes in food habits have accelerated the consumption of junk foods, which are the leading causes of several disorders that turn the majority of the people to use various herbal formulations or drugs for preventing various lifestyle diseases. Nutraceuticals are the borderline apparatus between nutrients and drugs that provide supplementation of the particular nutrient with a favorable health effect.

Objective: Various nutraceutical compounds like vitamins, spices, polyphenols, prebiotics, and probiotics in the form of powders, tablets, and capsules are currently marketed globally. Among them, previous literature have reported that polyphenols are the most promising compounds that have been proven to treat various chronic diseases like cancer, hypertension, diabetes mellitus (DM), osteoporosis, osteoarthritis, dyslipidemia, multiple sclerosis, congenital anomalies, Alzheimer’s disease, etc. It is warranted to discuss the benefits of nanoformulations of nutraceuticals.

Methods: We have searched PubMed using the keywords nutraceuticals, nanoformulations, therapeutic approaches, bionanotechnology, and therapeutics. The relevant papers and classical papers in this field were selected to write this review.

Results and Discussion: The different classifications of nutraceuticals were described in this review. The comparison between the different categories of nutraceuticals with their nanoformulated forms was made, explaining the benefits of nanoformulations regarding stability, bioavailability, enhanced anti-oxidant properties, etc. A glimpse of the drawbacks of nanoformulations was also included.

Conclusion: The current review highlights an overview of various nanoformulated nutraceuticals and their approach towards the treatment of multiple diseases.

Keywords: Nutraceuticals, nanoformulations, therapeutic approaches, bionanotechnology, therapeutics, flavanoids.

« Previous Next »
Graphical Abstract

[1]
Ramaa CS, Shirode AR, Mundada AS, Kadam VJ. Nutraceuticals--an emerging era in the treatment and prevention of cardiovascular diseases. Curr Pharm Biotechnol 2006; 7(1): 15-23.
[http://dx.doi.org/10.2174/138920106775789647] [PMID: 16472130]
[2]
Saldanha SN, Trygve OT. The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes J Oncol 2012; 1-13.
[3]
Girigoswami KB, Bhaumik G, Ghosh R. Bose (Girigoswami) K. Induced resistance in cells exposed to repeated low doses of H2O2 involves enhanced activity of antioxidant enzymes. Cell Biol Int 2005; 29(9): 761-7.
[http://dx.doi.org/10.1016/j.cellbi.2005.05.001] [PMID: 16087365]
[4]
Bose K, Bhaumik Girigoswami, Ghosh R. Chronic low dose exposure to hydrogen peroxide changes sensitivity of V79 cells to different damaging agents. Indian J Exp Biol 2003; 41(8): 832-6.
[PMID: 15248480]
[5]
Munir S, Shah AA, Shahid M, et al. Anti-angiogenesis potential of phytochemicals for the therapeutic management of tumors. Curr Pharm Des 2020; 26(2): 265-78.
[http://dx.doi.org/10.2174/1381612826666191230142638] [PMID: 31886747]
[6]
Onaolapo AY, Onaolapo OJ. Nutraceuticals and diet-based phytochemicals in type 2 diabetes mellitus: from whole food to components with defined roles and mechanisms. Curr Diabetes Rev 2019; 16(1): 12-25.
[http://dx.doi.org/10.2174/1573399814666181031103930] [PMID: 30378500]
[7]
Öztürk Y, Öztürk N. Plant- and Nutraceutical-based approach for the management of Diabetes and its Neurological complications: a narrative review. Curr Pharm Des 2019; 25(33): 3536-49.
[http://dx.doi.org/10.2174/1381612825666191014165633] [PMID: 31612820]
[8]
Jesus M, Silva T, Cagigal C, Martins V, Silva C. Dietary patterns: a new therapeutic approach for depression? Curr Pharm Biotechnol 2019; 20(2): 123-9.
[http://dx.doi.org/10.2174/1389201019666180925122116] [PMID: 30255747]
[9]
Karim N, Khan H, Khan I, et al. An increasing role of polyphenols as novel therapeutics for Alzheimer’s: a review. Med Chem 2020; 16(8): 1007-21.
[http://dx.doi.org/10.2174/1573406415666191105154407] [PMID: 31702507]
[10]
Huidrom S. Therapeutic approach of probiotic in children with Atopic Dermatitis. Antiinflamm Antiallergy Agents Med Chem 2020. Epub ahead of print
[http://dx.doi.org/10.2174/1871523019666200102110317] [PMID: 31899681]
[11]
D’Angelo S, Scafuro M, Meccariello R. BPA and nutraceuticals, simultaneous effects on endocrine functions. Endocr Metab Immune Disord Drug Targets 2019; 19(5): 594-604.
[http://dx.doi.org/10.2174/1871530319666190101120119] [PMID: 30621569]
[12]
Uribe NG, García-Galbis MR, Espinosa RMM. New advances about the effect of vitamins on human health: vitamins supplements and nutritional aspects. In: Maria CH. In: Functional Food - Improve Health through Adequate Food. UK: In Tech Open 2017.
[http://dx.doi.org/10.5772/intechopen.69122]
[13]
Yashin A, Yashin Y, Xia X, Nemzer B. Antioxidant activity of spices and their impact on human health: a review. Antioxidants 2017; 6(3): 70.
[http://dx.doi.org/10.3390/antiox6030070] [PMID: 28914764]
[14]
Kabak B, Dobson ADW. Mycotoxins in spices and herbs-An update. Crit Rev Food Sci Nutr 2017; 57(1): 18-34.
[http://dx.doi.org/10.1080/10408398.2013.772891] [PMID: 26528824]
[15]
Rezac S, Kok CR, Heermann M, Hutkins R. Fermented foods as a dietary source of live organisms. Front Microbiol 2018; 9: 1785.
[http://dx.doi.org/10.3389/fmicb.2018.01785] [PMID: 30197628]
[16]
Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutr Clin Care 2004; 7(2): 56-68.
[PMID: 15481739]
[17]
Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res 1993; 53(17): 3914-8.
[PMID: 8358717]
[18]
Drago L. Probiotics and colon cancer. Microorganisms 2019; 7(3): 66.
[http://dx.doi.org/10.3390/microorganisms7030066] [PMID: 30823471]
[19]
Dai FJ, Chau CF. Classification and regulatory perspectives of dietary fiber. Yao Wu Shi Pin Fen Xi 2017; 25(1): 37-42.
[http://dx.doi.org/10.1016/j.jfda.2016.09.006] [PMID: 28911542]
[20]
Cory H, Passarelli S, Szeto J, Tamez M, Mattei J. The role of polyphenols in human health and food systems: a mini-review. Front Nutr 2018; 5: 87.
[http://dx.doi.org/10.3389/fnut.2018.00087] [PMID: 30298133]
[21]
Klejdus B, Lojková L, Plaza M, Snóblová M, Stěrbová D. Hyphenated technique for the extraction and determination of isoflavones in algae: ultrasound-assisted supercritical fluid extraction followed by fast chromatography with tandem mass spectrometry. J Chromatogr A 2010; 1217(51): 7956-65.
[http://dx.doi.org/10.1016/j.chroma.2010.07.020] [PMID: 20701916]
[22]
Kim HS, Quon MJ, Kim JA. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol 2014; 2: 187-95.
[http://dx.doi.org/10.1016/j.redox.2013.12.022] [PMID: 24494192]
[23]
Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74(4): 418-25.
[http://dx.doi.org/10.1093/ajcn/74.4.418] [PMID: 11566638]
[24]
Fraga CG, Galleano M, Verstraeten SV, Oteiza PI. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Aspects Med 2010; 31(6): 435-45.
[http://dx.doi.org/10.1016/j.mam.2010.09.006] [PMID: 20854840]
[25]
Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000; 130(8S)(Suppl.): 2073S-85S.
[http://dx.doi.org/10.1093/jn/130.8.2073S] [PMID: 10917926]
[26]
D’Archivio M, Filesi C, Varì R, Scazzocchio B, Masella R. Bioavailability of the polyphenols: status and controversies. Int J Mol Sci 2010; 11(4): 1321-42.
[http://dx.doi.org/10.3390/ijms11041321] [PMID: 20480022]
[27]
Singla RK, Dubey AK, Garg A, et al. Natural polyphenols: chemical classification, definition of classes, subcategories, and structures. J AOAC Int 2019; 102(5): 1397-400.
[http://dx.doi.org/10.1093/jaoac/102.5.1397] [PMID: 31200785]
[28]
Helal NA, Eassa HA, Amer AM, Eltokhy MA, Edafiogho I, Nounou MI. Nutraceuticals’ novel formulations: the good, the bad, the unknown and patents involved. Recent Pat Drug Deliv Formul 2019; 13(2): 105-56.
[http://dx.doi.org/10.2174/1872211313666190503112040] [PMID: 31577201]
[29]
Pandey M, Verma RK, Saraf SA. Nutraceuticals: new era of medicine and health. Asian J Pharm Clin Res 2012; 3(1): 11-5.
[30]
Witkamp RF, van Norren K. Let thy food be thy medicine….when possible. Eur J Pharmacol 2018; 836: 102-14.
[http://dx.doi.org/10.1016/j.ejphar.2018.06.026] [PMID: 29936236]
[31]
Nasri H, Baradaran A, Shirzad H, Rafieian-Kopaei M. New concepts in nutraceuticals as alternative for pharmaceuticals. Int J Prev Med 2014; 5(12): 1487-99.
[PMID: 25709784]
[32]
Cushen M, Kerry J, Morris M, Cruz-Romero M, Cummins E. Nanotechnologies in the food industry – recent developments, risks and regulation. Trends Food Sci Technol 2012; 24(1): 30-46.
[http://dx.doi.org/10.1016/j.tifs.2011.10.006]
[33]
Yoshinori M, Eunice L-C, Bo J. Biological active food proteins and peptides in health: an overview Bioactive proteins and peptides as functional foods and nutraceuticals (1st Ed) Germany Blackwell Publishing Ltd . 2010; pp. 5-12.
[34]
Gera M, Sharma N, Ghosh M, et al. Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget 2017; 8(39): 66680-98.
[http://dx.doi.org/10.18632/oncotarget.19164] [PMID: 29029547]
[35]
Yavarpour-Bali H, Ghasemi-Kasman M, Pirzadeh M. Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders. Int J Nanomedicine 2019; 14: 4449-60.
[http://dx.doi.org/10.2147/IJN.S208332] [PMID: 31417253]
[36]
Wong KE, Ngai SC, Chan KG, Lee LH, Goh BH, Chuah LH. Curcumin nanoformulations for colorectal cancer: a review. Front Pharmacol 2019; 10: 152.
[http://dx.doi.org/10.3389/fphar.2019.00152] [PMID: 30890933]
[37]
Hewlings SJ, Kalman DS. Curcumin: a review of its’ effects on human health. Foods 2017; 6(10): 92.
[http://dx.doi.org/10.3390/foods6100092] [PMID: 29065496]
[38]
Chu C, Deng J, Man Y, Qu Y. Green tea extracts epigallocatechin-3-gallate for different treatments. Biomed Res Int 2017; 2017: 1-9.
[http://dx.doi.org/10.1155/2017/5615647]
[39]
EFSA. Scientific opinion on the safety of green tea catechins EFSA J. 2018; 16: p. (4)5239..
[40]
Siddiqui IA, Adhami VM, Bharali DJ, et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res 2009; 69(5): 1712-6.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-3978] [PMID: 19223530]
[41]
Zu YG, Yuan S, Zhao XH, Zhang Y, Zhang XN, Jiang R. [Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles]. Yao Xue Xue Bao 2009; 44(5): 525-31. [PMID: 19618731]
[42]
Sanna V, Pintus G, Roggio AM, et al. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. J Med Chem 2011; 54(5): 1321-32.
[http://dx.doi.org/10.1021/jm1013715] [PMID: 21306166]
[43]
Italia JL, Datta P, Ankola DD, Kumar MNVR. Nanoparticles enhance per oral bioavailability of poorly available molecules: epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solution. J Biomed Nanotechnol 2008; 4: 304-12.
[http://dx.doi.org/10.1166/jbn.2008.341]
[44]
Rocha S, Generalov R, Pereira MdoC, Peres I, Juzenas P, Coelho MAN. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Nanomedicine (Lond) 2011; 6(1): 79-87.
[http://dx.doi.org/10.2217/nnm.10.101] [PMID: 21182420]
[45]
Smith A, Giunta B, Bickford PC, Fountain M, Tan J, Shytle RD. Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3- gallate (EGCG) for the treatment of Alzheimer’s disease. Int J Pharm 2010; 389(1-2): 207-12.
[http://dx.doi.org/10.1016/j.ijpharm.2010.01.012] [PMID: 20083179]
[46]
Bigelow RL, Cardelli JA. The green tea catechins, (-)-epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 2006; 25(13): 1922-30.
[http://dx.doi.org/10.1038/sj.onc.1209227] [PMID: 16449979]
[47]
Shutava TG, Balkundi SS, Vangala P, et al. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano 2009; 3(7): 1877-85.
[http://dx.doi.org/10.1021/nn900451a] [PMID: 19534472]
[48]
Dube A, Ng K, Nicolazzo J, Larson I. Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution. Food Chem 2010; 122: 662-7.
[http://dx.doi.org/10.1016/j.foodchem.2010.03.027]
[49]
Dube A, Nicolazzo JA, Larson I. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate. Eur J Pharm Sci 2010; 41(2): 219-25.
[http://dx.doi.org/10.1016/j.ejps.2010.06.010] [PMID: 20600878]
[50]
Chamcheu JC, Siddiqui IA, Adhami VM, et al. Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis. Int J Nanomedicine 2018; 13: 4189-206.
[http://dx.doi.org/10.2147/IJN.S165966] [PMID: 30057446]
[51]
Elattar TM, Virji AS. Effect of tea polyphenols on growth of oral squamous carcinoma cells in vitro. Anticancer Res 2000; 20(5B): 3459-65.
[PMID: 11131648]
[52]
Lim YC, Lee SH, Song MH, et al. Growth inhibition and apoptosis by (-)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells. Eur J Cancer 2006; 42(18): 3260-6.
[http://dx.doi.org/10.1016/j.ejca.2006.07.014] [PMID: 17045795]
[53]
Khafif A, Schantz SP, al-Rawi M, Edelstein D, Sacks PG. Green tea regulates cell cycle progression in oral leukoplakia. Head Neck 1998; 20(6): 528-34.
[http://dx.doi.org/10.1002/(SICI)1097-0347(199809)20:6<528::AID-HED7>3.0.CO;2-3] [PMID: 9702540]
[54]
Masuda M, Suzui M, Weinstein IB. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2001; 7(12): 4220-9.
[PMID: 11751523]
[55]
Yamamoto T, Digumarthi H, Aranbayeva Z, et al. EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase. Toxicol Appl Pharmacol 2007; 224(3): 318-25.
[http://dx.doi.org/10.1016/j.taap.2006.11.013] [PMID: 17196232]
[56]
Lin HY, Hou SC, Chen SC, et al. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells. J Agric Food Chem 2012; 60(10): 2480-9.
[http://dx.doi.org/10.1021/jf204362n] [PMID: 22313388]
[57]
D’Andrea G. Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia 2015; 106: 256-71.
[http://dx.doi.org/10.1016/j.fitote.2015.09.018] [PMID: 26393898]
[58]
Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 2009; 133(3): 238-44.
[http://dx.doi.org/10.1016/j.jconrel.2008.10.002] [PMID: 18951932]
[59]
Barras A, Mezzetti A, Richard A, et al. Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int J Pharm 2009; 379(2): 270-7.
[http://dx.doi.org/10.1016/j.ijpharm.2009.05.054] [PMID: 19501139]
[60]
Wu TH, Yen FL, Lin LT, Tsai TR, Lin CC, Cham TM. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int J Pharm 2008; 346(1-2): 160-8.
[http://dx.doi.org/10.1016/j.ijpharm.2007.06.036] [PMID: 17689897]
[61]
Pool H, Quintanar D, Figueroa JD, et al. Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles J Nanomater 2012; 1-12.
[62]
Ghosh A, Mandal AK, Sarkar S, Panda S, Das N. Nanoencapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats. Life Sci 2009; 84(3-4): 75-80.
[http://dx.doi.org/10.1016/j.lfs.2008.11.001] [PMID: 19036345]
[63]
Ghosh S, Dungdung SR, Chowdhury ST, et al. Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress. Free Radic Biol Med 2011; 51(10): 1893-902.
[http://dx.doi.org/10.1016/j.freeradbiomed.2011.08.019] [PMID: 21914470]
[64]
Chakraborty S, Stalin S, Das N, Choudhury ST, Ghosh S, Swarnakar S. The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat. Biomaterials 2012; 33(10): 2991-3001.
[http://dx.doi.org/10.1016/j.biomaterials.2011.12.037] [PMID: 22257724]
[65]
Kumari A, Yadav SK, Pakade YB, Singh B, Yadav SC. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf B Biointerfaces 2010; 80(2): 184-92.
[http://dx.doi.org/10.1016/j.colsurfb.2010.06.002] [PMID: 20598513]
[66]
Mercader-Ros MT, Lucas-Abellán C, Fortea MI, Gabaldón JA, Núñez-Delicado E. Effect of HP-ß-cyclodextrins complexation on the antioxidant activity of flavonols. Food Chem 2010; 118: 769-73.
[http://dx.doi.org/10.1016/j.foodchem.2009.05.061]
[67]
Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444(7117): 337-42.
[http://dx.doi.org/10.1038/nature05354] [PMID: 17086191]
[68]
Agustin-Salazar S, Gamez-Meza N, Medina-Juàrez LA, Soto- Valdez H, Cerruti P. From nutraceutics to materials: effect of resveratrol on the stability of polylactide. ACS Sustain Chem& Eng 2014; 2: 1534-42.
[http://dx.doi.org/10.1021/sc5002337]
[69]
Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004; 32(12): 1377-82.
[http://dx.doi.org/10.1124/dmd.104.000885] [PMID: 15333514]
[70]
Salehi B, Mishra AP, Nigam M, et al. Resveratrol: a double-edged sword in health benefits. Biomedicines 2018; 6(3): 91.
[http://dx.doi.org/10.3390/biomedicines6030091] [PMID: 30205595]
[71]
Vitaglione P, Sforza S, Galaverna G, et al. Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res 2005; 49(5): 495-504.
[http://dx.doi.org/10.1002/mnfr.200500002] [PMID: 15830336]
[72]
Caddeo C, Teskac K, Sinico C, Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm 2008; 363(1-2): 183-91.
[http://dx.doi.org/10.1016/j.ijpharm.2008.07.024] [PMID: 18718515]
[73]
Shao J, Li X, Lu X, et al. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces 2009; 72(1): 40-7.
[http://dx.doi.org/10.1016/j.colsurfb.2009.03.010] [PMID: 19395246]
[74]
Singh G, Pai RS. Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential. Expert Opin Drug Deliv 2014; 11(5): 647-59.
[http://dx.doi.org/10.1517/17425247.2014.890588] [PMID: 24661109]
[75]
Singh G, Pai RS. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration. J Pharm Pharmacol 2014; 66(8): 1062-76.
[PMID: 24779896]
[76]
Zu Y, Zhang Y, Wang W, et al. Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles. Drug Deliv 2016; 23(3): 981-91.
[http://dx.doi.org/10.3109/10717544.2014.924167] [PMID: 24918466]
[77]
Teskac K, Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm 2010; 390(1): 61-9.
[http://dx.doi.org/10.1016/j.ijpharm.2009.10.011] [PMID: 19833178]
[78]
Pandita D, Kumar S, Poonia N, Lather V. Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Res Int 2014; 62: 1165-74.
[http://dx.doi.org/10.1016/j.foodres.2014.05.059]
[79]
Neves AR, Lúcio M, Martins S, Lima JL, Reis S. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int J Nanomedicine 2013; 8: 177-87.
[PMID: 23326193]
[80]
Jose S, Anju SS, Cinu TA, Aleykutty NA, Thomas S, Souto EB. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int J Pharm 2014; 474(1-2): 6-13.
[http://dx.doi.org/10.1016/j.ijpharm.2014.08.003] [PMID: 25102112]
[81]
Pando D, Caddeo C, Manconi M, Fadda AM, Pazos C. Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol. J Pharm Pharmacol 2013; 65(8): 1158-67.
[http://dx.doi.org/10.1111/jphp.12093] [PMID: 23837583]
[82]
Coimbra M, Isacchi B, van Bloois L, et al. Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. Int J Pharm 2011; 416(2): 433-42.
[http://dx.doi.org/10.1016/j.ijpharm.2011.01.056] [PMID: 21291975]
[83]
Basavaraj S, Betageri GV. Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol. Expert Opin Drug Deliv 2014; 11(4): 493-503.
[http://dx.doi.org/10.1517/17425247.2014.878701] [PMID: 24456117]
[84]
Lu X, Ji C, Xu H, et al. Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress. Int J Pharm 2009; 375(1-2): 89-96.
[http://dx.doi.org/10.1016/j.ijpharm.2009.03.021] [PMID: 19481694]
[85]
Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech 2011; 12(1): 279-86.
[http://dx.doi.org/10.1208/s12249-011-9584-3] [PMID: 21240574]
[86]
Karthikeyan S, Hoti SL, Prasad NR. Resveratrol loaded gelatin nanoparticles synergistically inhibits cell cycle progression and constitutive NF-kappaB activation, and induces apoptosis in non-small cell lung cancer cells. Biomed Pharmacother 2015; 70: 274-82.
[http://dx.doi.org/10.1016/j.biopha.2015.02.006] [PMID: 25776512]
[87]
Sharma K, Kumar V, Kaur J, et al. Health effects, sources, utilization and safety of tannins: a critical review. Toxin Rev 2019.
[http://dx.doi.org/10.1080/15569543.2019.1662813]
[88]
Aviram M, Rosenblat M, Gaitini D, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 2004; 23(3): 423-33.
[http://dx.doi.org/10.1016/j.clnu.2003.10.002] [PMID: 15158307]
[89]
Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L. Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J Med Food 2004; 7(3): 305-8.
[http://dx.doi.org/10.1089/jmf.2004.7.305] [PMID: 15383223]
[90]
Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 2001; 158(1): 195-8.
[http://dx.doi.org/10.1016/S0021-9150(01)00412-9] [PMID: 11500191]
[91]
Kulkarni AP, Mahal HS, Kapoor S, Aradhya SM. In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin. J Agric Food Chem 2007; 55(4): 1491-500.
[http://dx.doi.org/10.1021/jf0626720] [PMID: 17243704]
[92]
Mertens-Talcott SU, Jilma-Stohlawetz P, Rios J, Hingorani L, Derendorf H. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J Agric Food Chem 2006; 54(23): 8956-61.
[http://dx.doi.org/10.1021/jf061674h] [PMID: 17090147]
[93]
Kim ND, Mehta R, Yu W, et al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 2002; 71(3): 203-17.
[http://dx.doi.org/10.1023/A:1014405730585] [PMID: 12002340]
[94]
Albrecht M, Jiang W, Kumi-Diaka J, et al. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food 2004; 7(3): 274-83.
[http://dx.doi.org/10.1089/jmf.2004.7.274] [PMID: 15383219]
[95]
Shibata T, Ishimaru K, Kawaguchi S, Yoshikawa H, Hama Y. Antioxidant activities of phlorotannins isolated from Japanese Laminariaceae. J Appl Phycol 2008; 20: 705-11.
[http://dx.doi.org/10.1007/s10811-007-9254-8]
[96]
Bala I, Bhardwaj V, Hariharan S, Kumar MN. Analytical methods for assay of ellagic acid and its solubility studies. J Pharm Biomed Anal 2006; 40(1): 206-10.
[http://dx.doi.org/10.1016/j.jpba.2005.07.006] [PMID: 16111850]
[97]
Lei F, Xing DM, Xiang L, et al. Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 796(1): 189-94.
[http://dx.doi.org/10.1016/S1570-0232(03)00610-X] [PMID: 14552830]
[98]
Li Z, Percival SS, Bonard S, Gu L. Fabrication of nanoparticles using partially purified pomegranate ellagitannins and gelatin and their apoptotic effects. Mol Nutr Food Res 2011; 55(7): 1096-103.
[http://dx.doi.org/10.1002/mnfr.201000528] [PMID: 21374799]
[99]
Arulmozhi V, Pandian K, Mirunalini S. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerfaces 2013; 110: 313-20.
[http://dx.doi.org/10.1016/j.colsurfb.2013.03.039] [PMID: 23732810]
[100]
Bala I, Bhardwaj V, Hariharan S, Kharade SV, Roy N, Ravi Kumar MNV. Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration. J Drug Target 2006; 14(1): 27-34.
[http://dx.doi.org/10.1080/10611860600565987] [PMID: 16603449]
[101]
Sonaje K, Italia JL, Sharma G, Bhardwaj V, Tikoo K, Kumar MN. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res 2007; 24(5): 899-908.
[http://dx.doi.org/10.1007/s11095-006-9207-y] [PMID: 17377747]
[102]
Shirode AB, Bharali DJ, Nallanthighal S, Coon JK, Mousa SA, Reliene R. Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention. Int J Nanomedicine 2015; 10: 475-84.
[PMID: 25624761]
[103]
D’Andria R, Di Salle A, Petillo O, Sorrentino G, Peluso G. Nutraceutical, cosmetic, health products derived from olive. Present and future of the Mediterranean olive sector Options méditerranéennes SERIES A: Mediterranean Seminars, CIHEAM 2013; OM A106 2013; 153-61.
[104]
Saija A, Trombetta D, Tomaino A, et al. In vitro evaluation of the antioxidant activity and biomembrane interaction of the plant phenols oleuropein and hydroxytyrosol. Int J Pharm 1998; 166: 123-33.
[http://dx.doi.org/10.1016/S0378-5173(98)00018-0]
[105]
Kesente M, Kavetsou E, Roussaki M, et al. Encapsulation of olive leaves extracts in biodegradable PLA nanoparticles for use in cosmetic formulation. Bioengineering (Basel) 2017; 4(3): 75.
[http://dx.doi.org/10.3390/bioengineering4030075] [PMID: 28952554]
[106]
Hussain Z, Katas H, Mohd Amin MC, Kumolosasi E, Buang F, Sahudin S. Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model. Int J Pharm 2013; 444(1-2): 109-19.
[http://dx.doi.org/10.1016/j.ijpharm.2013.01.024] [PMID: 23337632]
[107]
Katas H, Amin MCI, Sahudin S, Buang F. Chitosan-based skin-targeted nanoparticle drug delivery system and method WIPO(PCT). WO2015072846A1, 2013.
[108]
Siddique MI, Katas H, Amin MCIM, et al. Minimization of local and systemic adverse effects of topical glucocorticoids by nanoencapsulation: in vivo safety of hydrocortisone–hydroxytyrosol loaded chitosan nanoparticles. J Pharm Sci 2015; 104(12): 4276-86.
[http://dx.doi.org/10.1002/jps.24666] [PMID: 26447747]
[109]
Guan Q, Sun S, Li X, et al. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol. J Mater Sci Mater Med 2016; 27(2): 24.
[http://dx.doi.org/10.1007/s10856-015-5641-x] [PMID: 26704541]
[110]
López-García MA, López O, Maya Fernández-Bolaños JG. Complexation of hydroxytyrosol with ß-cyclodextrins. An efficient photoprotection. Tetrahedron 2010; 66: 8006-11.
[http://dx.doi.org/10.1016/j.tet.2010.08.009]
[111]
Mohammadi A, Jafari SM, Assadpour E, Faridi Esfanjani A. Nano-encapsulation of olive leaf phenolic compounds through WPC-pectin complexes and evaluating their release rate. Int J Biol Macromol 2016; 82: 816-22.
[http://dx.doi.org/10.1016/j.ijbiomac.2015.10.025] [PMID: 26459167]
[112]
Kerdudo A, Dingas A, Fernandez X, Faure C. Encapsulation of rutin and naringenin in multilamellar vesicles for optimum antioxidant activity. Food Chem 2014; 159: 12-9.
[http://dx.doi.org/10.1016/j.foodchem.2014.03.005] [PMID: 24767021]
[113]
Tsai M-J, Huang Y-B, Fang J-W, Fu Y-S, Wu P-C. Preparation and characterization of naringenin-loaded elastic liposomes for topical application. PLoS One 2015; 10(7): e0131026.
[http://dx.doi.org/10.1371/journal.pone.0131026] [PMID: 26158639]
[114]
Yousuf S, Muthu Vijayan Enoch IV. Binding interactions of naringenin and naringin with calf thymus DNA and the role of β-cyclodextrin in the binding. AAPS PharmSciTech 2013; 14(2): 770-81.
[http://dx.doi.org/10.1208/s12249-013-9963-z] [PMID: 23625651]
[115]
Wang Y, Wang S, Firempong CK, et al. Enhanced solubility and bioavailability of naringenin via liposomal nanoformulation: preparation and in vitro and in vivo evaluations. AAPS PharmSciTech 2017; 18(3): 586-94.
[http://dx.doi.org/10.1208/s12249-016-0537-8] [PMID: 27151135]
[116]
Wen J, Liu B, Yuan E, Ma Y, Zhu Y. Preparation and physicochemical properties of the complex of naringenin with hydroxypropyl-β-cyclodextrin. Molecules 2010; 15(6): 4401-7.
[http://dx.doi.org/10.3390/molecules15064401] [PMID: 20657449]
[117]
Yen F-L, Wu T-H, Lin L-T, Cham T-M, Lin C-C. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. Pharm Res 2009; 26(4): 893-902.
[http://dx.doi.org/10.1007/s11095-008-9791-0] [PMID: 19034626]
[118]
Krishnakumar N, Sulfikkarali N, Rajendra Prasad N, Karthikeyan S. Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Biomed Prev Nutr 2011; 1(4): 223-31.
[http://dx.doi.org/10.1016/j.bionut.2011.09.003]
[119]
Panneerselvam S, Kumpati P. Formulation characterization and pharmacokinetic evaluation of naringenin- loaded gastroretentive mucoadhesive polymeric nanosystem for oral drug delivery. J Drug Deliv Ther 2015; 5(2): 107-14.
[120]
Amin FU, Shah SA, Badshah H, Khan M, Kim MO. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ1-42-induced oxidative stress. J Nanobiotechnology 2017; 15(1): 12.
[http://dx.doi.org/10.1186/s12951-016-0227-4] [PMID: 28173812]
[121]
Gokuladhas K, Jayakumar S, Madankumar A, et al. Synthesis and characterization of biocompatible gold nanoparticles stabilized with hydrophilic polymer coated hesperetin drug for sustained drug delivery to treat hepatocellular carcinoma-derived cancer cells. J Pharm Res 2014; 8(2): 98-105.
[122]
Girigoswami K. Toxicity of Metal Oxide Nanoparticles. Adv Exp Med Biol 2018; 1048: 99-122.
[http://dx.doi.org/10.1007/978-3-319-72041-8_7] [PMID: 29453535]

Rights & Permissions Print Cite
Article Metrics
39
© 2024 Bentham Science Publishers | Privacy Policy